Infection with Omicron after vaccination may weaken immunity to new variants later Infection with Omicron after vaccination may weaken immunity...
Month: June 2022
21:0 FDA panel unanimously approved to recommend approval of two COVID-19 vaccines for children 21:0 FDA panel unanimously approved...
Illumina recalls 1813 sequencers worldwide Illumina recalls 1813 sequencers worldwide. On the 13th, the US FDA's official website issued...
Pfizer COVID-19 oral drug Paxlovid: One Phase II/III clinical trial failed Pfizer COVID-19 oral drug Paxlovid: One Phase II/III clinical...
Nature: Amyloid beta is not the cause of Alzheimer's disease Nature: Amyloid beta is not the cause of Alzheimer's...
Stanford-Yale research: Mild COVID-19 infection may still lead to nerve cell and myelin disorders Stanford-Yale research: Mild COVID-19 infection...
FDA approves Alnylam's RNAi therapy Amvuttra FDA approves Alnylam's RNAi therapy Amvuttra. On June 13, Alnylam announced that the...
Most promising breakthroughs: Drug candidate for breast cancer will start clinical trials Most promising breakthroughs: Drug candidate for breast...
More than 500 new drugs for blood diseases are in development. More than 500 new drugs for blood diseases...
Clinical results of Moderna's Omicron vaccine are more broad-spectrum than original vaccine Clinical results of Moderna's Omicron vaccine are...
Amylyx's ALS drug gets conditional approval in Canada Amylyx's ALS drug gets conditional approval in Canada. The first in...
The booster of COVID-19 vaccine by Sanofi and GlaxoSmithKline effective against Omicron The booster of COVID-19 vaccine by Sanofi...
Why don't we remember things that happened in infancy? Why don't we remember things that happened in infancy? Whenever...
FDA approves oral JAK inhibitor baricitinib for the treatment of alopecia areata FDA approves oral JAK inhibitor baricitinib for...
Innovative treatment for childhood brain tumors: Phase II trials of Tovorafenib is successful Innovative treatment for childhood brain tumors:...
Canadian regulator approves Albrioza to launch innovative approach to ALS Canadian regulator approves Albrioza to launch innovative approach to...
2022 Top 50 global pharmaceutical companies 2022 Top 50 global pharmaceutical companies The US Pharmaceutical Executive "Pharmaceutical Manager"...
Harvard Scientists Develop a Revolutionary New Treatment for Diabetes Harvard Scientists Develop a Revolutionary New Treatment for Diabetes.Type 1...
Study finds higher-than-average blood sugar increases heart attack risk Study finds higher-than-average blood sugar increases heart attack risk The...
1 suspected "cat spreading COVID-19 to human" case appeared 1 suspected "cat spreading COVID-19 to human" case appeared Recently, Thailand...
Scientists identify 117 genes that may lead to type 2 diabetes Scientists identify 117 genes that may lead to...
How do genetic mutations cause tissue-specific cancers? How do genetic mutations cause tissue-specific cancers? Renal lineage factor PAX8 controls...
Probiotics can support the effects of antidepressants and help relieve depression Probiotics can support the effects of antidepressants and...
What are the challenges and solutions for CAR-T therapy? What are the challenges and solutions for CAR-T therapy? Chimeric...
First time: Clinical cure of solid tumor archived only by drugs First time: Clinical cure of solid tumor archived...
How do oncolytic viruses work in CAR-T therapy? Science Translational Medicine: How do oncolytic viruses work in CAR-T therapy? The...
FDA panel unanimously backs bluebird gene therapy FDA panel unanimously backs bluebird gene therapy. On June 11, bluebird...
FGFR inhibitors demonstrate efficacy in 14 cancer types FGFR inhibitors demonstrate efficacy in 14 cancer types. Janssen, a Johnson &...
AHS 2022: AbbVie Biohaven Teva announce latest researches on migraine drugs AHS 2022: AbbVie Biohaven Teva announce latest researches on migraine drugs. ...
FDA reviewers say Moderna COVID-19 vaccine is safe and effective for children under 5 FDA reviewers say Moderna COVID-19...